Skip To Main Content
Elie Dolgin on Muck Rack

Elie Dolgin

Verified
Somerville
As seen in: Medium, MSN, The New York Times, The New York Times en Español, UOL, British Journal of Cancer, El País, Nature, The Washington Post, Aol and
Science journalist
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elie

Contact Elie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Elie Dolgin’s Biography

Read Full Bio →

Elie Dolgin, a news editor at STAT, swapped worms for words. He studied nematodes for his PhD at the University of Edinburgh, before working as an associate editor at The Scientist and as a senior news editor at Nature Medicine. Elie’s writing has appeared in Discover, Scientific American, Nautilus, Tablet Magazine, and elsewhere. He once tried out for the Israeli national curling team.

Articles

An HIV vaccine is within reach

|
By Elie Dolgin Verified
| Yahoo Verified
In January 2025, Linda-Gail Bekker stood inside a vaccine manufacturing plant and allowed herself to believe that the first HIV vaccine candidate conceived through African science and led by Africans might finally become a reality. Key takeaways HIV has stubbornly resisted prevention via a vaccine. But in mRNA, scientists think they have finally found a technology to develop one.
Open in Who Shared Issue with article?

An HIV vaccine is within reach

|
By Elie Dolgin Verified
| Future Perfect Verified
In January 2025, Linda-Gail Bekker stood inside a vaccine manufacturing plant and allowed herself to believe that the first HIV vaccine candidate conceived through African science and led by Africans might finally become a reality. HIV has stubbornly resisted prevention via a vaccine. But in mRNA, scientists think they have finally found a technology to develop one. mRNA, which was used for the successful Covid vaccines, is a way to agilely iterate and develop new candidate vaccines quickly.
Open in Who Shared Issue with article?

An HIV vaccine is within reach

|
By Elie Dolgin Verified
| brnw.ch
Elie Dolgin is a science journalist in Somerville, Massachusetts, covering biomedical research and drug discovery. In January 2025, Linda-Gail Bekker stood inside a vaccine manufacturing plant and allowed herself to believe that the first HIV vaccine candidate conceived through African science and led by Africans might finally become a reality. HIV has stubbornly resisted prevention via a vaccine. But in mRNA, scientists think they have finally found a technology to develop one.
Open in Who Shared Issue with article?
See all 406 licensed articles (437 Total)